Alembic Pharmaceuticals has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 41.25% fall in its net profit at Rs 103.52 crore for the quarter ended June 30, 2025 as compared to Rs 176.19 crore for the same quarter in the previous year. However, the total income of the company increased by 1.57% at Rs 1501.96 crore for Q1FY26 as compared to Rs 1478.70 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 14.60% rise in its net profit at Rs 154.38 crore for Q1FY26 as compared to Rs 134.71 crore for the same quarter in the previous year. The total income of the company increased by 9.81% at Rs 1717.22 crore for Q1FY26 as compared to Rs 1563.83 crore for the corresponding quarter previous year.
